Sfoglia per AUTORE
BORELLI B
Collezione ASL Biella

  

Items : 2

Modified FOLFOXIRI plus cetuximab and avelumab as initial therapy in RAS wild-type unresectable metastatic colorectal cancer: Results of the phase II AVETRIC trial by GONO in Annals of Oncology

2023
ASL Biella

Conca V; Antoniotti C; Bergamo F; Pietrantonio F; Rossini D; Scartozzi M; Perissinotto E; Leone A; Pusceddu V; Borelli B; Cavanna L; Latiano T; Santini D; Masi G; Salvatore L; Frassineti G; Leone F; Tamberi S; Boni L; Cremolini C;

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer. in British journal of cancer / Br J Cancer. 2017 Jan;116(3):318-323. doi: 10.1038/bjc.2016.413. Epub 2017 Jan 12.

2017
ASL Biella
AO Cuneo

Cremolini C; Falcone A; Boni L; Tomcikova D; Paris M; Bonetti A; Martignetti A; Dargenio F; Miraglio E; Amoroso D; Banzi MC; Borelli B; Chiara S; Loupakis F; Masi G; Allegrini G; Barbara C; Salvatore L; Antonuzzo L; Marmorino F;